<bill session="108" type="h" number="2491" updated="2023-01-15T16:18:29Z">
  <state datetime="2003-06-17">REFERRED</state>
  <status>
    <introduced datetime="2003-06-17"/>
  </status>
  <introduced datetime="2003-06-17"/>
  <titles>
    <title type="display">Greater Access to Affordable Pharmaceuticals Act</title>
    <title type="official" as="introduced">Entitled the "Greater Access to Affordable Pharmaceuticals Act".</title>
    <title type="short" as="introduced">Greater Access to Affordable Pharmaceuticals Act</title>
  </titles>
  <sponsor bioguide_id="E000172"/>
  <cosponsors>
    <cosponsor bioguide_id="A000357" joined="2003-06-17"/>
    <cosponsor bioguide_id="B000403" joined="2003-06-17"/>
    <cosponsor bioguide_id="B001228" joined="2003-06-17"/>
    <cosponsor bioguide_id="B001246" joined="2003-06-17"/>
    <cosponsor bioguide_id="B000944" joined="2003-06-17"/>
    <cosponsor bioguide_id="B001149" joined="2003-06-17"/>
    <cosponsor bioguide_id="C000059" joined="2003-06-17"/>
    <cosponsor bioguide_id="C000754" joined="2003-06-17"/>
    <cosponsor bioguide_id="D000216" joined="2003-06-19"/>
    <cosponsor bioguide_id="E000063" joined="2003-06-17"/>
    <cosponsor bioguide_id="E000287" joined="2003-06-17"/>
    <cosponsor bioguide_id="G000536" joined="2003-06-17"/>
    <cosponsor bioguide_id="J000286" joined="2003-06-17"/>
    <cosponsor bioguide_id="K000172" joined="2003-10-16"/>
    <cosponsor bioguide_id="K000220" joined="2003-06-17"/>
    <cosponsor bioguide_id="L000559" joined="2003-06-17"/>
    <cosponsor bioguide_id="L000480" joined="2003-06-17"/>
    <cosponsor bioguide_id="M000133" joined="2003-06-17"/>
    <cosponsor bioguide_id="M000844" joined="2003-06-19"/>
    <cosponsor bioguide_id="N000002" joined="2003-06-19"/>
    <cosponsor bioguide_id="N000143" joined="2003-06-17"/>
    <cosponsor bioguide_id="O000165" joined="2003-06-17"/>
    <cosponsor bioguide_id="O000159" joined="2003-07-08"/>
    <cosponsor bioguide_id="P000034" joined="2003-06-17"/>
    <cosponsor bioguide_id="R000486" joined="2003-06-17"/>
    <cosponsor bioguide_id="S000033" joined="2003-06-19"/>
    <cosponsor bioguide_id="S001145" joined="2003-10-30"/>
    <cosponsor bioguide_id="S000248" joined="2003-06-17"/>
    <cosponsor bioguide_id="S000597" joined="2003-11-05"/>
    <cosponsor bioguide_id="S001004" joined="2004-06-17"/>
    <cosponsor bioguide_id="W000119" joined="2003-06-17"/>
    <cosponsor bioguide_id="W000215" joined="2003-06-17"/>
    <cosponsor bioguide_id="W000314" joined="2003-06-17"/>
  </cosponsors>
  <actions>
    <action datetime="2003-06-17">
      <text>Introduced in House</text>
    </action>
    <action datetime="2003-06-17" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-06-17">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-06-24">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2003-06-25">
      <text>Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU03" name="House Judiciary" subcommittee="Courts, Intellectual Property, and the Internet" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="108" type="s" number="1225" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Antitrust law"/>
    <term name="Civil actions and liability"/>
    <term name="Commerce"/>
    <term name="Consent decrees"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Generic drugs"/>
    <term name="Government Operations and Politics"/>
    <term name="Intellectual property"/>
    <term name="Law"/>
    <term name="Marketing"/>
    <term name="Patent infringement"/>
    <term name="Patents"/>
    <term name="Pharmaceutical research"/>
    <term name="Punitive damages"/>
    <term name="Restrictive trade practices"/>
    <term name="Science, Technology, Communications"/>
  </subjects>
  <amendments/>
  <summary date="2003-10-17T21:50:24Z" status="Introduced in House">Greater Access to Affordable Pharmaceuticals Act - Amends the Federal Food, Drug, and Cosmetic Act to: (1) limit a brand name drug manufacturer to one Food and Drug Administration (FDA) 30-month stay of competition in a patent infringement suit against a generic drug applicant; (2) permit a generic applicant being sued to file a counterclaim to correct or delete patent information; (3) limit damages that a brand name manufacturer may recover in an instance where such manufacturer failed to file certain patent information; (4) permit a generic drug applicant to seek declaratory judgment regarding patent infringement prior to marketing a drug; (5) forfeit the180-day market exclusivity period for a first generic drug applicant to a subsequent generic applicant if the first applicant engages in certain activities which impede such drug's timely marketing; and (6) permit alternative means to determine bioequivalence for drugs that are not absorbed into the bloodstream.</summary>
</bill>
